Related Experiment Video
Updated: Sep 23, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes
1Tulane Diabetes Program, Department of Medicine, Section of Endocrinology, Tulane University Medical Center, SL-53, 1430 Tulane Avenue, New Orleans, Louisiana 70112-2699, USA. ptheuma@tulane.edu
Abstract:
Morbidity and mortality from diabetes mellitus remain high despite managing the traditional risk factors. Recent data imply that the pathophysiology of macrovascular and microvascular complications involve other factors. The metabolic syndrome precedes the onset of type 2 diabetes by many years. Early treatment of individuals with this syndrome might delay the onset of diabetes and its complications. Endothelial dysfunction, subclinical inflammation and impaired fibrinolysis may contribute to progression of macrovascular as well as microvascular complications. The roles of infection and hyperhomocysteinemia are less clear but may be significant. This review discusses the current knowledge on these "non-traditional" risk factors and therapies to improve them.
Insights
Managing diabetes mellitus complications requires addressing non-traditional risk factors beyond traditional ones. Early intervention for metabolic syndrome may prevent type 2 diabetes and its vascular issues.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Metabolic Diseases
Background:
- Diabetes mellitus continues to cause significant morbidity and mortality, even with management of traditional risk factors.
- Emerging evidence suggests non-traditional factors play a crucial role in the pathophysiology of diabetic macrovascular and microvascular complications.
- Metabolic syndrome often precedes type 2 diabetes, indicating a potential window for early intervention.
Purpose of the Study:
- To review current knowledge on non-traditional risk factors for diabetes complications.
- To discuss potential therapies targeting these non-traditional risk factors.
- To explore the role of metabolic syndrome in delaying diabetes onset and complications.
Main Methods:
- Literature review of recent data on non-traditional risk factors.
- Discussion of pathophysiological mechanisms including endothelial dysfunction, inflammation, and impaired fibrinolysis.
- Exploration of the potential significance of infection and hyperhomocysteinemia.
Main Results:
- Endothelial dysfunction, subclinical inflammation, and impaired fibrinolysis are implicated in the progression of both macrovascular and microvascular complications.
- The roles of infection and hyperhomocysteinemia in diabetes progression warrant further investigation.
- Early treatment of metabolic syndrome may delay the onset of type 2 diabetes and its associated complications.
Conclusions:
- Addressing non-traditional risk factors is essential for improving outcomes in diabetes mellitus.
- Targeting metabolic syndrome and associated factors like endothelial dysfunction and inflammation may offer new therapeutic strategies.
- Further research is needed to clarify the roles of infection and hyperhomocysteinemia in diabetes complications.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetic Retinopathy
Coronary Artery Disease I: Introduction
Diabetic Nephropathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications